Zacks Investment Research
07 Aug 2026, 00:31 UTC · 1h ago
Progyny (PGNY) Reports Q2 Earnings: What Key Metrics Have to Say
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.
Zacks Investment Research
07 Aug 2026, 00:31 UTC · 1h ago
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.
What the story claims
3 claims · each scored for market impact
Progyny reported a quarterly EPS of $0.55, beating the Zacks Consensus Estimate of $0.51 by 7.84%. — A meaningful earnings beat typically triggers positive short-term price action as it demonstrates stronger profitability than analysts expected.
+0.40Progyny's quarterly revenue reached $350.51 million, a 5.3% increase year-over-year. — Steady year-over-year growth indicates fundamental business expansion, though the growth rate is modest.
+0.20Progyny's reported revenue exceeded the Zacks Consensus Estimate by 0.38%. — While positive, a beat of less than 1% is marginal and unlikely to drive significant market volatility on its own.
+0.10Which stocks this story touches
Continue reading
6 related stories
Top 3 movers · tap to explore
The company reported revenue and EPS that both exceeded Zacks Consensus Estimates.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
How the impact breaks down
Where the story's weight lands
Stocks most exposed
Modeled from each name's sensitivity to this story
No stock impact ranking available yet.
Zacks Investment Research
36m ago
